Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary
productive time of their life. The symptoms of MS can restrict the individual's physical activity …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

The aim of this systematic review is to collect and summarize all current data on the indirect
costs related to absenteeism and presenteeism associated with multiple sclerosis. Searches …

Background In an era of scarce resources, policy makers, neurologists and other
stakeholders need to be aware of the economic burden of multiple sclerosis and the cost …

Objectives: To estimate average annual cost per multiple sclerosis (MS) patient in the US
using published estimates from the literature. Methods: A search was performed of English …

Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

Background Multiple sclerosis has both high healthcare and social impacts. Objective The
purpose of this article is to analyse the available literature describing the economic burden …

Introduction and objective Multiple sclerosis (MS) is a chronic inflammatory disease of the
central nervous system. MS is considered incurable; however, disease treatment has …

OBJECTIVE: To derive robust estimates for the cost of multiple sclerosis (MS) based on a
variety of cost factors across a number of different cost perspectives. This is essential to …